Short answer
agilon health, inc. (AGL) filed an 8-K current report with the SEC on November 4, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Press release covers agilon health’s third-quarter and nine-month results through September 30, 2026.
agilon health, inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Press release covers agilon health’s third-quarter and nine-month results through September 30, 2026
- Investors should review Exhibit 99.1 for reported financial performance and management commentary
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $1.52B, up 6% YoY despite total platform membership declining 8% to 566,000
- MSER improved to 88.5% from 104.0%, driving net income $35M versus a $110M loss
- Adjusted EBITDA reached $64M versus negative $91M, signaling substantial operating turnaround
- FY2026 guidance raised: revenue $5.87B-$5.89B and Adjusted EBITDA $145M-$155M
- Membership outlook remains lower, with year-end Medicare Advantage members guided to 445,000-450,000 and total platform members to 553,000-562,000
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other agilon health, inc. 8-K filings
Get the next AGL 8-K as it lands
Follow AGL for push alerts, or ask the research agent what this filing means.